Pieris Pharmaceuticals completes private placement of units

Pieris Pharmaceuticals Inc. (NASDAQ:PIRS), Boston, Mass.
Business: Autoimmune, Inflammation,

Read the full 92 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE